FDA Panel Disses Angina Gadget; COVID-Cardio Research Faulted; House Rehabilitation

 FDA Panel Disses Angina Gadget; COVID-Cardio Research Faulted; House Rehabilitation

An FDA advisory panel considered the Neovasc Reducer gadget safe for treating refractory angina however almost all voted against its efficacy, the business revealed.(BioSpace)

Just 7%of COVID-19 scientific trials center on cardiovascular treatments, and even those were primarily single center and smaller sized, an analysis of ClinicalTrials.gov reported in the American Heart Journal

Cardiology research study on COVID-19 has been a ” disastrous failure,” states Larry Husten of CardioBrief

COVID-19 patients revealed small capillary blood circulation problems and, in those on mechanical ventilation, serious endothelial glycocalyx damage. ( Angiogenesis and Biophysical Journal)

Cardiac arrest clients with COVID-19 were most likely to need mechanical ventilation and had greater death, whether ejection fraction was low or not. ( Journal of the American College of Cardiology)

Diabetes patients on statins had lower in-hospital COVID-19 death. ( Journal of the American Heart Association)

Home-based heart rehab with telemonitoring and training was much better than nothing for senior citizens, a trial reported in JAMA Cardiology

The Big Ten justified its choice

Read More

Redak staff

Leave a Reply

Your email address will not be published.